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The Influence of Biofilm on the Antifungal Activity of Amine Oxide
Abstract
Denture-related stomatitis (DRS) is the most common oral disease affecting denture wearers today, and is
characterized by inflammation of the denture bearing mucosa. In a search through historical dental
literature for the most often suspected culprit of DRS, one will repeatedly find first listed the fungus
Candida albicans. While C. albicans can be isolated from the fitting surfaces of dentures, and the
supporting mucosa of patients suffering from DRS, it is also found in the oral cavity of 65% of the human
population—most of which is free from oral disease. A truth puzzling to investigators, the discovery of a
self-produced, protective matrix present around colonies of communal bacteria and fungi (or biofilm)
began to shed light on that troubling finding.
Various investigators have shown that fungal cells in a biofilm community tend to be more resistant to
anti-fungal agents than freshly grown cells. Further, it is has been shown that organisms thrive in a biofilm
environment, and can behave differently than when they are out of the community. It is not clearly
understood, however, why these changes occur. Regardless, C. albicans and its cell components can elicit
stimulation of inflammatory cytokines by human monocytes, in vitro, and it is believed that this interaction
with monocytes likely leads to the gingival inflammation evident in DRS.
Post-infection therapies for DRS are known to the profession. Prescription antifungal creams alone or in
combination with tissue conditioning are tried-and-true methods of treating DRS, however, effective
preventive interventions are not readily available. If found, preventive therapy initiated before the onset of
DRS could prevent the most common disease affecting denture wearers today.
The current study focused on the influence of the surfactant amine oxide (AO) on fresh C. albicans and C.
albicans cultured from biofilms, and the subsequent impact of that interaction on human monocyte
production of IL-1β and TNF-α. This study also addressed the impact that AO has on biofilm formation by
examining the viability of cells cultured from that AO-modified matrix. If found effective, AO may be
valuable in preventing or reducing the incidence of DRS mediated by the fungal pathogen C. albicans.
Elucidating the differences between the interaction of fresh and biofilm grown C. albicanswith human
monocytes will help clarify the specific host response to this fungal pathogen and shed light on its effect
on the chemical mediators of DRS.
Currently, chemical biocides are used to control microbial growth and plaque accumulation. Those agents
include sodium hypochlorite and various surfactants. As previously mentioned, this study assessed the
antifungal activity of the surfactant AO. The hypotheses of this study are: (1) AO is fungistatic and
fungicidal against C. albicans; (2) AO will prevent or reduce fungal biofilm formation on denture acrylic
surfaces; and (3) biofilm grown C. albicans will stimulate human monocytes to secrete a greater amount
of inflammatory cytokines than cells derived from fresh culture.
Results of this study indicate a significant difference in both viability and monocyte stimulatory ability
following exposure to AO between both fresh and biofilm-cultured cells. The degree of AO activity was
found to be time and concentration dependent as higher concentrations of AO and higher exposure times
to AO were found more effective at killing fungal cells. Further, AO was found effective in altering some
protective characteristic of biofilms. The presence of the surfactant during matrix formation rendered
inhabitant cells more subject to AO’s antifungal activity than cells cultured from biofilms allowed to
develop outside the presence of AO.
These results suggest that AO is effective at reducing the number of viable C. albicans cells isolated from
fresh and biofilm culture, as well as fungal cells located in a biofilm environment. Further, this series of
experiments suggest that by reducing the number of viable fungal cells, AO is also capable of indirectly

decreasing the activity of human monocytes to release the inflammatory cytokines IL-1β and TNF-α.
Future investigations should address the intraoral applications of AO, and its effectiveness in a clinical
setting.
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ABSTRACT
Denture-related stomatitis (DRS) is the most common oral disease affecting
denture wearers today, and is characterized by inflammation of the denture bearing
mucosa. In a search through historical dental literature for the most often suspected
culprit of DRS, one will repeatedly find first listed the fungus Candida albicans. While
C. albicans can be isolated from the fitting surfaces of dentures, and the supporting
mucosa of patients suffering from DRS, it is also found in the oral cavity of 65% of the
human population—most of which is free from oral disease. A truth puzzling to
investigators, the discovery of a self-produced, protective matrix present around colonies
of communal bacteria and fungi (or biofilm) began to shed light on that troubling finding.
Various investigators have shown that fungal cells in a biofilm community tend to
be more resistant to anti-fungal agents than freshly grown cells. Further, it is has been
shown that organisms thrive in a biofilm environment, and can behave differently than
when they are out of the community. It is not clearly understood, however, why these
changes occur. Regardless, C. albicans and its cell components can elicit stimulation of
inflammatory cytokines by human monocytes, in vitro, and it is believed that this
interaction with monocytes likely leads to the gingival inflammation evident in DRS.
Post-infection therapies for DRS are known to the profession. Prescription
antifungal creams alone or in combination with tissue conditioning are tried-and-true
methods of treating DRS, however, effective preventive interventions are not readily
available. If found, preventive therapy initiated before the onset of DRS could prevent
the most common disease affecting denture wearers today.
The current study focused on the influence of the surfactant amine oxide (AO) on
fresh C. albicans and C. albicans cultured from biofilms, and the subsequent impact of
that interaction on human monocyte production of IL-1β and TNF-α. This study also
addressed the impact that AO has on biofilm formation by examining the viability of cells
cultured from that AO-modified matrix. If found effective, AO may be valuable in
preventing or reducing the incidence of DRS mediated by the fungal pathogen C.
albicans. Elucidating the differences between the interaction of fresh and biofilm grown
C. albicans with human monocytes will help clarify the specific host response to this
fungal pathogen and shed light on its effect on the chemical mediators of DRS.
Currently, chemical biocides are used to control microbial growth and plaque
accumulation on denture surfaces. Those agents include sodium hypochlorite and various
surfactants. As previously mentioned, this study assessed the antifungal activity of the
surfactant AO. The hypotheses of this study are: (1) AO is fungistatic and fungicidal
against C. albicans; (2) AO will prevent or reduce fungal biofilm formation on denture
acrylic surfaces; and (3) biofilm grown C. albicans will stimulate human monocytes to
secrete a greater amount of inflammatory cytokines than cells derived from fresh culture.
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Results of this study indicate a significant difference in both viability and
monocyte stimulatory ability following exposure to AO between both fresh and biofilmcultured cells. The degree of AO activity was found to be time and concentration
dependent as higher concentrations of AO and higher exposure times to AO were found
more effective at killing fungal cells. Further, AO was found effective in altering some
protective characteristic of biofilms. The presence of the surfactant during matrix
formation rendered inhabitant cells more subject to AO’s antifungal activity than cells
cultured from biofilms allowed to develop outside the presence of AO.
These results suggest that AO is effective at reducing the number of viable
C. albicans cells isolated from fresh and biofilm culture, as well as fungal cells located in
a biofilm environment. Further, this series of experiments suggest that by reducing the
number of viable fungal cells, AO is also capable of indirectly decreasing the activity of
human monocytes to release the inflammatory cytokines IL-1β and TNF-α. Future
investigations should address the intraoral applications of AO, and its effectiveness in a
clinical setting.
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CHAPTER 1. INTRODUCTION
Dr. Poul Petersen perhaps said it best in a 2005 article when he stated, “A
demographic revolution is underway” (1). According to studies conducted by the United
Nations, the age group categorized as older persons (those over 60) is growing faster than
any other age group. It is estimated that world-wide, over 600 million people are over the
age of 60, and it is further figured that this number will double over the next 25 years and
more than triple in the next 50 years, reaching the billions. Eighty-percent of those
individuals will live in industrialized countries, with close to 100 million living in the
U.S. by the year 2050 (1).
In America, 26% of individuals 60 and older are edentulous (2). Of this 26% of
today’s population, many are wearing complete dentures that are not properly
maintained. While the suggested life span of a complete denture is between 5-7 years
(3), literature suggests that the average denture in America is approximately 17.6 years
old (4)! When a denture is in service for more than 7 years, it is frequently necessary that
it be lined to maintain adequate fit and retention. Sadly, few seek proper care for their
‘over-worked’ prosthesis, and as a result much soft and hard tissue irritation and
remodeling may result, leading to what is commonly referred to as ‘denture-related
stomatitis’ (DRS). DRS is an inflammatory process of the mucosa that has been found to
occur in 45-60% of the denture wearing population (5).
In the absence of proper denture hygiene, an environment (or biofilm) favorable
for the proliferation of microorganisms may develop. A biofilm is defined as a structured
community of microorganisms surrounded by a self-produced polymeric matrix that is
adherent to an inert or living surface (6). It consists of a thick layer of bacteria, yeast,
and desquamated epithelial cells containing more than one-trillion organisms per gram in
wet weight. Without mechanical and/or chemical removal of this biofilm, a network of
fungal and bacterial microorganisms may form between the intaglio surface of a
prosthesis, and the opposing soft tissue, likely resulting in DRS (7). C. albicans can
usually be isolated from a biofilm on both the fitting surface of the denture and the
denture-bearing mucosa of DRS patients (5).
While in most cases a candida infection can be controlled with antifungal
medications (either locally or systemically), control is difficult in persons with
immunodeficiencies (e.g., HIV/AIDS) (8). In fact, organisms may become resistant to
standard therapy, so prevention is key.
Surfactants (surface-active-agents) are used in a variety of household products as
emulsifying agents to trap dirt, oils, bacteria, and other debris located on skin, clothes,
dishes, and even dentures. Surfactants are simple molecules consisting of a hydrophilic
head (i.e., N = O) and hydrophobic tail (long carbon chain) (9). Amine Oxide (AO; C10C16-alkyldimethyl N-oxides) is an example of a surfactant. AO is an amphoteric,
cationic surfactant. These surfactants are not only very mild (making them useful for
personal care and household cleaning products), but also have a disinfecting/sanitizing
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property (imparted by the cationic nature of the molecule) (9) that has recently found an
oral application. In a study by Fraud, et al., AO was found to be an excellent biocide for
eliminating Streptococcus mutans biofilms from hydroxyapetite discs (10,11). No
research has been done on the efficacy of AO as a biocide to eliminate C. albicans from
denture acrylic surfaces. If found effective at reducing biofilm formation and/or its
ability to harbor viable fungal cells, AO could promise to be a mechanism of prevention
of DRS that currently evades the profession.
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CHAPTER 2. REVIEW OF LITERATURE
Polymethyl Methacrylate (PMMA)
The principal type of material utilized for the fabrication of oral and maxillofacial
prostheses is heat-activated PMMA (12). It has remained a predictable and effective tool
in dentistry for the past nearly seventy years namely because it is not only economical,
but easy to use (13). Technology is no stranger to denture acrylic, as its advancements
have consistently improved the properties of PMMA since its inception in 1937 (13).
However, one property not likely to be eliminated in heat-cured PMMA is the issue of
porosity. The polymerization of heat-processed denture acrylic is an exothermic reaction
initiated by a heat-activated chemical element (14). While porosity is less of an issue at
the surface of the acrylic, the body of the material remains at risk due to boiling monomer
within the depth of the acrylic caused by poor conduction of heat by the material itself.
The product of this reaction is a very stable and strong material that although seemingly
completely dense remains essentially a porous structure.
The Complete Denture
A common prosthesis fabricated using PMMA is the complete denture. The
denture base derives its support through intimate contact with the underlying oral tissues
(14), a result not easily achieved even at delivery of a new prosthesis. Conventionally
heat-cured, compression molded PMMA has a volumetric shrinkage of 7% and linear
shrinkage of less than 1% on average (14). The need of clinical and laboratory remounts
along with adjustment of the intaglio surface of the new prosthesis evidence these minor,
yet significant changes from the pre-processed state of the complete denture (15).
Likened to a time capsule by some authors, a complete denture remains, over time, an
accurate representation of the state of the denture bearing oral mucosa at the time of
master impression in creation of the prosthesis.
The lifespan of a complete denture is not clearly defined in literature due in part
to the subjective nature of that determination, however, anecdotally, 5-7 years is an
accepted term of many (3). The need for a new prosthesis by the patient remains the true
definer of the lifespan of a complete denture, and is usually a result of lack of fit, and a
consequent decrease in function. While that finding is expected to occur in the 5-10 year
range, the vast majority of denture wearers are more hopeful, with the average complete
denture in America being 17.6 years old (4).
With an increase in age of an un-modified prosthesis comes a decrease in its
stability as a result in the non-intimate contact of its intaglio surface to the underlying
mucosa. What is created at that point is a space sufficient for the retention of food,
saliva, denture adhesive, and native bacteria and fungi.
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Candida albicans
Candida albicans is the most common fungus isolated from the human oral
cavity, being found in over 65% of the population. Introduction into the oral cavity may
occur via many routes including kissing others whose mouths are colonized by the
fungus, to ingesting contaminated processed and unprocessed food (16). It is a
polymorphic fungus consisting of a thick cell wall that preferentially colonizes mucosal
surfaces of the GI tract. Components of the cell wall (adhesins) mediate the binding of C.
albicans to other cells (host or microbial), inert polymers, or proteins (16). It is this
adhesion that allows C. albicans to colonize the oral cavity. Without adhesion, the yeast
cells would be washed out by saliva and swallowed (16). While C. albicans will grow
more quickly and reach higher cell concentrations in moist environments (16), if the
degree of contamination is high enough, cells can remain viable on dry surfaces for at
least 24 hours (16,17).
Biofilm
A biofilm is a structured community of micro-organisms surrounded by a selfproduced polymeric matrix, and is adherent to an inert or living surface (5,6). Biofilms
may easily form on intraoral prostheses in the absence of good oral hygiene. As a result,
a thick biofilm of bacteria, yeast, and desquamated epithelial cells containing more than
one-trillion organisms per gram in wet weight may quickly form. The biofilm matrix is
believed to alter the characteristics of its inhabitants through not only mechanical and
chemical protection from surrounding agents, but also from intimate interaction between
bacterial and fungal neighbors (18). In fact, certain mechanisms of phagocytosis of
fungal cells are ineffective when the fungus is located in this biofilm environment (19).
Biofilms have also been found effective at increasing the antifungal resistance of fungal
inhabitants. Lamfon, et al. has shown that biofilms can increase the antifungal resistance
of its fungal tenants up to one thousand times over that of planktonically grown cells
(20). Without mechanical and/or chemical removal of this biofilm, this network of
fungal and bacterial microorganisms may persist on the intaglio surface of a prosthesis
likely resulting in the type of local tissue inflammation characteristic of DRS (7).
Denture-Related Stomatitis (DRS)
A disease characterized by a lesion that is almost invariably asymptomatic and
usually affects the hard palate, DRS is defined as an inflammatory process of the mucosa
underlying a removable, partial, or total dental prosthesis or appliance (7). Candida
albicans has been associated with DRS since 1936 (21), and remains one of the most
suspected major agents of this disease process. While the pathogenesis of DRS is not
fully understood, it is known that it is not an allergic reaction to C. albicans (22) that
leads to the characteristic inflammation associated with the disease. There are, however,
many other theories and models of likely modes of infection. Whether due to invasive
forms of the fungus (23), a compromised state of the immune system (24), or alteration of
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the typical monocyte release of inflammatory cytokines and their mediators (25), denture
stomatitis remains a persistent problem for dentists and their edentulous patients. What is
consistent throughout literature is the consensus on the first step in the infection process
of DRS: the adherence of C. albicans to oral epithelial cells. Without that mechanism,
the fungus would be unable to overcome the normal flushing of saliva through the oral
cavity, and would not be able to reach an infective number of colony forming units in its
habitat (26). When invaded by C. albicans, oral epithelial cells are the frontline defense
mechanism of the body, releasing large numbers of pro-inflammatory and
immunoregulatory cytokines including IL-1β and TNF-α (27). These cytokines are
believed to target cell surface components of C. albicans. While this mechanism is
effective, various studies have shown the ability of C. albicans to modify the
characteristics of its cell surface based on not only the temperature of its environment,
but also the pH and nutrient content (25,28) of the oral cavity. Other recently reported
cell-mediated fungicidal mechanisms involve the hyaluronic acid that is bound to the
epithelial cell wall and excreted by the cell itself (29). The mechanism of action of
hyaluronic acid has not been identified.
The fungus maintains in its own defense not only the ability to modify its own
cell surface characteristics (as earlier described), but also to fabricate a protective matrix
or biofilm. Perhaps more effective in evading host defensive mechanisms, the biofilm
environment provides not only a physical barrier to clearance mechanisms of the oral
cavity and host cells, but also serves as a venue for phenotypic alteration of its inhabitants
(18,20). Reports in literature attribute this physical barrier and eventual phenotypic
alteration as significant contributors to DRS initiation and perpetuation as well as a
platform to developed resistance to traditional antifungal therapies (18,20,30). Factoring
in the belief that poorly fitting dentures predispose to a candida infection by breaking
down the epithelial barrier (31) of the oral cavity, the pathogenicity and astonishing
number of individuals that experience DRS becomes less of an enigma.
According to literature, 65% of current denture wearers will experience DRS at
one point in their lifetimes, resulting in not only localized, chronic inflammation, but also
modification of the denture bearing mucosa, thus making stability of the complete
denture an exception, instead of a rule. PMMA used to fabricate complete dentures
serves as a perfect environment for colonization by bacteria and fungi. Micro-porosity of
the denture base combined with space present beneath an ill-fitting prosthesis
accommodate the colonization of these surfaces by biofilms of fungi and bacteria (31).
Large levels of colonization and tissue invasion create a situation not easily overcome by
the traditional tissue conditioning and antifungal therapy. Some authors propose the
eventual use of immunomodulatory drugs to treat denture stomatitis hoping to alter the
host response to fungus invasion (32). However, as identified by Perezous, et al.,
treatments aimed at only the intraoral condition of the infection may result in an
immediate decrease in inflammation, but the effect is short lived if the fungus is not
eliminated from the denture surface as well (24).
Studies of the effectiveness of surface charges on acrylic resin to inhibit fungus
hyphae attachment are reported in recent literature (33,34,35). Commercially available
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denture cleaning agents have also undergone the scrutiny of recent research (36). While
both reports claim effective prevention of fungal cell attachment to acrylic surfaces, they
do not address prevention or dissolution of biofilm attachment. Also, neither group of
studies purports a fungicidal or fungistatic mechanism to their experimental material. As
reported collectively in literature on DRS, there is a clear need for further investigation of
factors that may moderate the adhesion of organisms and subsequent colonization of
denture base materials and oral mucosa.
Amine Oxide
Surfactants (surface-active-agents) are used in a variety of household products as
emulsifying agents to trap dirt, oils, bacteria, and other debris located on skin, clothes,
dishes, and even dentures. Surfactants are simple molecules consisting of a hydrophilic
head (i.e., N=O) and hydrophobic tail (long carbon chain) (9). Discovered and studied
before 1900 (37), amine oxide (AO; C10-C16-alkyldimethyl N-oxides) is an example of
a surfactant. AO is an amphoteric, cationic surfactant. These surfactants are not only
very mild (making them useful for personal care and household cleaning products), but
also have a disinfecting/sanitizing property (imparted by the cationic nature of the
molecule) (9) that has recently found an oral application. In a study by Fraud, et al., AO
was found to be an excellent biocide for eliminating Streptococcus mutans biofilms from
hydroxyapetite discs (10,11). However, efforts to apply AO as a surfactant to control
C. albicans in complete denture patients with DRS have not been investigated.

6

CHAPTER 3. RESEARCH OBJECTIVES
DRS is an errythematous inflammatory reaction of the denture bearing mucosal
layer of the oral cavity. Candida albicans (the most common fungal pathogen associated
with DRS) has been shown to cause significant problems in both healthy and immunocompromised individuals (24). The ability of C. albicans to colonize denture material
and readily form biofilms imparts to the fungus a resistance to antifungal agents (18,20).
This may constitute a significant public health problem, particularly in immunocompromised individuals (24). Blocking fungal colonization and biofilm formation on
denture base material in an effort to prevent C. albicans-mediated DRS has been
identified as a ‘clear need’in reviews on the topic (21).
Studies have shown that C. albicans and cell components elicit stimulation of
inflammatory cytokines by human monocytes, in vitro (25,27,28). However, the
interaction of biofilm grown C. albicans versus freshly cultured cells with human
monocytes has not been studied. It is possible that biofilm-grown cells differ in either
their ability to stimulate human monocyte release of different types cytokines, different
quantities of cytokines, or both.
Studies have demonstrated that a biofilm environment evokes changes in
microorganisms, whereby biofilm-associated organisms behave differently than freshly
cultured cells (18,20). Such changes have been further demonstrated by various
investigators by studying the differences in C. albicans sensitivity to commonly used
antifungal agents. Determining how these changes may alter a host response to
C. albicans may prove useful. Thus, a comparison of the interaction of freshly-grown
C. albicans with human monocytes to biofilm-grown C. albicans with human monocytes
was accomplished in this project.
The bacteriostatic and bactericidal activity of AO on several microorganisms has
recently been reported (10,11). AO has been shown to possess anti-bacterial function,
and to reduce oral streptococcal plaque and biofilm formation. This prompted us to
further investigate the antifungal activity of AO, and examine AO’s ability to prevent the
formation and/or dissipation of biofilm formed on denture acrylic surfaces by
C. albicans. The following specific aims and hypotheses were formulated to focus this
study.
Specific Aim I
Study the fungicidal and fungistatic properties of AO on freshly cultured and
biofilm-grown C. albicans. It is hypothesized that AO is fugistatic and fungicidal against
C. albicans.
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Specific Aim II
Investigate the effect of AO on (a) the formation of C. albicans biofilm formation
on PMMA discs and (b) Study the effect of AO on the preformed biofilm on PMMA
discs. It is hypothesized that AO will prevent or reduce fungal biofilm formation on
denture acrylic surfaces.
Specific Aim III
Investigate the interaction of freshly cultured and biofilm-grown C. albicans
extracts with cultured monocytic THP-1 cells to secrete cytokines, IL-1β and TNF-α. It
is hypothesized that biofilm-grown C. albicans will be a better stimulant of monocyte
secreted inflammatory cytokines than the freshly cultured cells.
The results of this study may help clarify the pathogenic role of C. albicans in and
out of a biofilm environment. Results may also identify AO as a valuable agent in
controlling DRS mediated by C. albicans.
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CHAPTER 4. METHODS AND MATERIALS
Amine Oxide
The AO, N,N-dimethyldodecylamine N-oxide solution (C14H31NO), was obtained
from Sigma-Aldrich Chemical Co. (St. Louis, MO). AO was diluted to a concentration
of 0.1% (stock) in saline and then two-fold dilutions of the AO were prepared (up to
0.001%).
Fungal Strains
C. albicans (ATCC 44505) maintained in the UTHSC Dental Research Center
was grown for 24 hours at 37 °C in Sabouraud-dextrose broth (SDB; Difco Laboratories)
in an orbital water bath shaker at 60 rpm to obtain stationary-phase yeast cells. Cells
were harvested by centrifugation at 4 °C and washed twice with phosphate-buffered
saline (PBS; pH 7.2). Suspension of C. albicans were prepared by measuring the
absorbance of the cells at 600 nm and counted under a light microscope to determine the
number of yeast cells per milliliter. The suspension was adjusted to a concentration of 1 x
105 colony-forming units (CFU) per milliliter, and used in experiments as a standard cell
suspension. The cells were examined microscopically to verify non-budding yeast phase,
and used immediately.
Denture Substrate Material
Two-millimeter thick sheets of conventionally heat-activated polymethyl
methacrylate (PMMA) were processed according to manufacturer’s specifications
(Densply Trubyte, Densply International). Sheets were cut into circular discs of 7mm in
diameter. The discs were stored in purified water for seven days to remove any residual
monomer. The discs were disinfected by dipping them in 70% alcohol for one minute,
and washed with sterile, distilled water before experimental use. The discs were
routinely tested for sterility.
Preparation of Fungal Biofilms
Paraffin-stimulated whole human saliva was collected from 20 healthy volunteers
in 50 mL sterile tubes, and was kept in a beaker of ice. The saliva was clarified by
centrifugation (10,000 x g; 20 minutes; 4 °C). The samples were kept on ice during
collection in order to avoid any enzymatic degradation. PMMA discs were incubated
with clarified whole human saliva for 8 hours at 37 °C. Discs were removed and washed
with PBS and then used in C. albicans adhesion assays and biofilm formation.
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Saliva-coated PMMA discs were incubated with 500 µl of standardized cell
suspension of C. albicans (105 cells/mL) and incubated for 3 hours at 37 °C on a rocker.
The discs were gently washed with PBS, agitated to ensure the removal of non-adherent
cells and then transferred to a new plate. After this adhesion phase the discs were
immersed in SDB medium with 50mM of glucose and incubated on a rocker table for 72
hours for biofilm formation. The number of adherent fungal cells were determined by
XTT (sodium 3*-[1-(phenylamino-carbonyl)-3,4-tetrazolium]-bis (4-methoxy-6-nitro)
benzene sulfonic acid hydrate; Roche Laboratories) assay.
Antifungal Activity of Amine Oxide
Freshly cultured and biofilm grown C. albicans were suspended to a stock
concentration of 1 x 105 cells/ml. Ten-fold dilutions of the stock fungal cells were then
made in saline. A two-fold dilution of AO was prepared (0.1% to 0.001%) in saline.
Equal amounts (0.5 mL) of AO and C. albicans (diluted as described above) were mixed
and incubated for 30 min at 37 °C. The viability of fungal cells after exposure to AO was
assayed by the XTT cell proliferation method.
XTT Cell Proliferation Assay
The biofilm formation on PMMA discs was also measured by the metabolic
reduction of XTT (sodium 3*-[1-(phenylamino-carbonyl)-3,4-tetrazolium]-bis (4methoxy-6-nitro) benzene sulfonic acid hydrate; Roche Laboratories) to a soluble
formazan product by yeast cells. The discs with biofilms were transferred to microtiter
plates that contained 100 µl PBS per well to which 50 µl of XTT reagent (final
concentration of XTT 0.3mg/ml) was added. Plates were incubated at 37 °C for two
hours. The absorbance of the supernatant was measured at 492nm using an ELISA
reader (Bio-Rad Laboratories). A standard curve with known number of fungal cells was
generated which enabled the determination of viable number of fungal cells. Fungal cells
were then collected by scraping the PMMA discs, washed with saline and adjusted to a
concentration of 1 x 105 cells/mL in preparation for assays.
THP-1 Cells
THP-1 cells (ATCC TIB 202) were grown in suspension in 75 cm2 plastic tissue
culture flasks (Corning Glass Works, Corning, N.Y.) in RPMI 1640 (GIBCO,
Gaithersburg, Md.) complete medium (CM) with addition of the antibiotics penicillin G
sodium (100 U/ml) and streptomycin sulfate (100 μg/mL) and supplemented with 10%
(vol/vol) heat-inactivated fetal bovine serum, and amino acids. Cells were incubated at 37
°C in a humidified atmosphere consisting of 5% CO2.
Suspensions of freshly grown and biofilm grown fungal cells (105 cells) were
exposed to varying concentrations of AO. The fungal cells were then subjected to mild
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sonication, keeping the cells on ice for 60 seconds, and then centrifuged. The cell
supernatants were collected, their protein concentration adjusted and then used in
cytokine assays. A suspension of THP-1 cells (1x105) was incubated with extracts of
fresh and biofilm C. albicans for 24 h at 37 °C. The culture supernatants were collected,
centrifuged and assayed for levels of cytokines.
IL-1β and TNF-α Cytokine Assay
THP-1 cells were incubated with extracts of gently sonicated fresh and biofilmcultured C. albicans cells (1 x 105) for 24 hours. Supernatant fluids of untreated THP-1
cells and those treated with extracts of freshly grown and biofilm grown C. albicans
(standardized to contain same amount of protein, determined by BioRad protein assay)
were stored at −80 °C until used for measurement of IL-1β and TNF-α secretion.
Cytokines released by THP-1 cells (when stimulated with fresh and biofilm grown
C.albicans) were measured with commercial enzyme-linked immunosorbent assay
(ELISA) kits (R & D Systems, Minneapolis, Minn.). The average absorbance values for
each triplicate set of standards, controls, and samples were calculated by using a standard
curve. Results were expressed as picograms of IL-1β or TNF-α per milliliter of
supernatant fluid.
Data Analysis
Each experiment was performed a minimum of three times, with triplicate
determinations at each point. Results were evaluated for statistical significance by
ANOVA followed by Scheffe’s f-test. Differences in results with a p-value less than 0.05
were considered significant.
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CHAPTER 5. RESULTS
Effect of pH on Antifungal Activity of AO
C. albicans (1 x 10 5 CFU/mL) from fresh and biofilm culture was treated with
0.001% AO at various pH values (4.5 to 7.0) for 10 minutes, and then assayed for cell
viability using the XTT method previously described. As demonstrated in Table 1 and
Figure 1, AO demonstrated antifungal activity within culture groups at all pH values.
However, AO’s antifungal activity differed between culture groups, affecting fungal cells
cultured from fresh environments more than cells cultured from biofilm environments.
AO activity was not statistically different within culture groups, but was found
statistically different between culture groups at p < 0.05.
Effect of AO on Adherence of C. albicans to PMMA Discs
Fresh C. albicans (1 x 105 CFU/mL) was combined with saliva-coated PMMA
and varying concentrations of AO (0.005%, 0.001%, 0.01%), and was allowed to
incubate for 3 hours at 37 °C. Fungal cells adhering to the discs following the incubation
period were assayed using the XTT method previously described. As demonstrated in
Table 2 and Figure 2, at increasing concentration of AO, the number of viable
C. albicans cells decreased. Cell viability was statistically different between all AO
concentration groups at p < 0.05.
Influence of AO on Salivary Pellicle Formation on PMMA Discs
Fresh C. albicans (1 x 105 CFU/mL) was combined with saliva and varying
concentrations of AO coated PMMA (0.0005% to 0.01%) that had been incubated for 8
hours at 37 °C. Following addition of the fungal cells, the mixture was allowed to
incubate further for 3 hours at 37 °C. As demonstrated in Table 3 and Figure 3, at
increasing concentration of AO, the number of viable C. albicans cells decreased. Cell
viability was statistically different between all AO concentration groups at p < 0.05.
Effect of AO Exposure Time on Viability of C. albicans
C. albicans (1 x 105 CFU/mL) from fresh and biofilm cultures was treated with
0.001% AO for varying periods of time (5 minutes to 60 minutes), and then assayed at
each time period for cell viability using the XTT method previously described. As
demonstrated in Table 4 and Figure 4, at increasing exposure time to AO, the number of
viable C. albicans cells decreased in both fresh and biofilm groups. However, a greater
number of viable cells from biofilm culture persisted in exposure times (20 minutes to 30
minutes) in which fresh cells could not survive. Cell viability was statistically different
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Table 1. Effect of pH on Antifungal Activity of AO.
Source
Fresh
Biofilm

pH 4.5
360 ± 40
870 ± 30

pH 5.0
470 ± 20
1120 ± 60

pH 5.5
540 ± 60
1070 ± 30

pH 6.0
490 ± 40
1210 ± 20

pH 7.0
410 ± 30
980 ±40

Number of Viable Cells

1400
Fresh Cells

1200

Biofilm Cells

1000
800
600
400
200
0
4.5

5.0

5.5
pH Value

6.0

7.0

Figure 1. Effect of pH on Antifungal Activity of AO.
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Table 2. Effect of AO on Adherence of C. albicans to PMMA Discs.

Number of Viable Cells

Concentration of AO
0
0.0005%
0.001%
0.01%

# of Cells
97500 ± 3200
3150 ± 280
960 ± 80
0

150000
140000
130000
120000
110000
100000
90000
80000
70000
60000
50000
40000
30000
20000
10000
0

# Cells

0

0.0005%
0.001%
0.01%
Concentration of Amine Oxide

Figure 2. Effect of AO on Adherence of C. albicans to PMMA Discs.
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Table 3. Influence of AO on Salivary Pellicle Formation on PMMA Discs.
Concentration of AO
0
0.0005%
0.001%
0.01%

# of Cells
95000 ± 3250
7800 ± 350
600 ± 300
150 ± 40

Number of Viable Cells

100000
# Cells

90000
80000
70000
60000
50000
40000
30000
20000
10000
0
0

0.0005%
0.001%
0.01%
Concentration of Amine Oxide

Figure 3. Influence of AO on Salivary Pellicle Formation on PMMA Discs.
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Table 4. Effect of AO Exposure Time on Viability of C. albicans.
Exposure Time
0 minutes
5 minutes
10 minutes
15 minutes
20 minutes
30 minutes
45 minutes
60 minutes

# Cells—Fresh
96500
980
460
120
0
0
0
0

# Cells—Biofilm
93000 ± 2600
12500 ± 1150
1050 ± 90
820 ± 60
440 ± 50
160 ± 30
0
0

Number of Viable Cells

200000
100000

Fresh Cells

10000

Biofilm Cells

1000
100
10

60 min

45 min

30 min

20 min

15 min

10 min

5 min

0 min

1

Time of Exposure

Figure 4. Effect of AO Exposure Time on Viability of C. albicans.
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between culture groups at all exposure times, and was also statistically different within
culture groups up to 20 minutes and 45 minutes for fresh and biofilm culture groups,
respectively (p < 0.05).
Effect of AO on Fresh and Biofilm-Cultured C. albicans
C. albicans (1 x 105 CFU/mL) from fresh and biofilm cultures was treated with
varying concentrations of AO (0.0001% to 0.01%) for 10 minutes, and then assayed for
cell viability using the XTT method previously described. As demonstrated in Table 5
and Figure 5, at increasing concentration of AO, the number of viable C. albicans
cells/mL decreased in both fresh and biofilm groups. However, a greater number of
viable cells from biofilm culture persisted in levels of AO concentration (0.005% to
0.1%) in which fresh cells could not survive. At AO concentrations of 0.0001% and
higher, cell viability was statistically different between and within both culture groups at
p < 0.05.
Effect of AO on Biofilm Formation on PMMA Discs
Fresh C. albicans (1 x 105 CFU/mL) was combined with saliva-coated PMMA
and allowed to incubate for 3 hours at 37 °C. Varying concentrations of AO (0.0001% to
0.005%) were then added to this environment for 10 minutes. Cells located in the biofilm
were sampled and assayed for cell viability using the XTT method previously described.
As demonstrated in Table 6 and Figure 6, at increasing concentration of AO, the number
of viable cells/mL decreased. Cell viability was statistically different between all AO
concentration groups at p < 0.05.
Effect of AO on IL-1β Secretion by THP-1 Cells
C. albicans (1 x 105 CFU/mL) from fresh and biofilm culture was exposed to
increasing concentrations of AO (0.0001% to 0.005%) for 10 minutes and then separately
pelleted and gently sonicated to obtain cell extracts The cell extract (100µL of mg/mL
stock) was used in the assay to stimulate THP-1 cells. The level of IL-1β secretion was
assayed using the ELISA method previously described. As demonstrated in Table 7 and
Figure 7, at increasing concentration of AO, the level of IL-1β stimulation decreased.
Further, a lower level of cytokine stimulation resulted from exposure to fresh culture cells
than from biofilm culture cells. While the level of IL-1β stimulation at different AO
concentrations was statistically different within each culture group (p < 0.05), the level of
stimulation was only statistically different between culture groups at AO concentration of
0.0001% (p < 0.05).
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Table 5. Effect of AO on Fresh and Biofilm-Cultured C. albicans.
Concentration of AO
0
0.0001%
0.0005%
0.001%
0.005%
0.01%
0.1%

# Cells—Fresh
95000 ± 3500
31000 ± 1250
1650 ± 200
480 ± 50
0
0
0

# Cells—Biofilm
93500 ± 1200
75000 ± 3500
4200 ± 450
950 ± 40
400 ± 80
120 ± 60
0

Number of Viable Cells

200000
100000

Fresh Cells

10000

Biofilm Cells

1000
100
10

0.1%

0.01%

0.005%

0.001%

0.0005%

0.0001%

0

1

Concentration of Amine Oxide

Figure 5. Effect of AO on Fresh and Biofilm-Cultured C. albicans.
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Table 6. Effect of AO on Biofilm Formation on PMMA Discs.
Concentration of AO
0
0.0001%
0.0005%
0.001%
0.005%

# of Cells
94300 ± 2900
37700 ± 800
2650 ± 380
670 ± 40
0

Number of Viable Cells

200000
100000

Biofilm Cells

10000
1000
100
10

0.005%

0.001%

0.0005%

0.0001%

0

1

Concentration of Amine Oxide

Figure 6. Effect of AO on Biofilm Formation on PMMA Discs.
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Table 7. Effect of AO on IL-1β Secretion by THP-1 Cells.
Concentration of AO
0
0.0001%
0.0005%
0.001%
0.005%

IL-1β Stimulated by Fresh
Cells (pg/mL)
270 ± 24
126 ± 18
74 ± 9
23 ± 5
12 ± 3

Number of Viable Cells

350

IL-1β Stimulated by
Biofilm Cells (pg/mL)
346 ± 21
178 ± 23
89 ± 14
36 ± 9
19 ± 6

Fresh Cells

300

Biofilm Cells

250
200
150
100
50
0.005%

0.001%

0.0005%

0.0001%

0

0

Concentration of Amine Oxide

Figure 7. Effect of AO on IL-1β Secretion by THP-1 Cells.
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Effect of AO on TNF-α Secretion by THP-1 Cells
C. albicans (1 x 105 CFU/mL) from fresh and biofilm cultures was exposed to
varying concentrations of AO (0.0001% to 0.005%) for 10 minutes and then separately
pelleted and gently sonicated to obtain cell extracts. The cell extract (100µL of mg/mL
stock) was used in the assay to stimulate THP-1 cells. The level of TNF-α secretion was
assayed using the ELISA method previously described. As demonstrated in Table 8 and
Figure 8, at increasing concentration of AO, the level of TNF-α stimulation decreased.
Further, the level of cytokine stimulation was lower for fresh culture cells than for
biofilm culture cells. TNF-α activity was statistically different between and within
culture groups at each AO concentration level at p < 0.05.
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Table 8. Effect of AO on TNF-α Secretion by THP-1 Cells.
Concentration of AO
0
0.0001%
0.0005%
0.001%
0.005%

TNF-α Stimulated by
Fresh Cells (pg/mL)
390 ± 41
286 ± 22
114 ±9
43 ± 8
19 ± 5

TNF-α Stimulated by
Biofilm Cells (pg/mL)
546 ± 38
338 ± 44
159 ± 21
76 ± 12
29 ± 6

600
Number of Viable Cells

Fresh Cells
500
Biofilm Cells
400
300
200
100

0.005%

0.001%

0.0005%

0.0001%

0

0

Concentration of Amine Oxide

Figure 8. Effect of AO on TNF-α Secretion by THP-1 Cells.
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CHAPTER 6. DISCUSSION
Effect of pH on Antifungal Activity of AO
The pH of human saliva may vary in several circumstances, including time of
day, proximity to meals, quantity and quality of saliva, type of diet, and state of oral
health (38). Of particular interest in this study is how a change in oral health evident in
DRS (which is known to lower the pH of the oral cavity) could effect the anti-fungal
activity of AO. Saliva collected from 20 healthy volunteers was pooled, and used
throughout the experimental procedure, and was found to have a pH of 6.5. Modification
of the pH of saliva samples separated from the pooled volume was accomplished by
acid/base additions. Results of this study show that a 0.0001% AO concentration when
exposed to fresh and biofilm-cultured C. albicans cells for a period of 10 minutes is not
significantly affected in its antifungal ability. Therefore, pH does not appear to alter the
effect that AO has on fungal cells derived from within and outside of a biofilm
environment.
Effect of AO on Adherence of C. albicans to PMMA Discs
An objective of tissue conditioning in DRS patients is prevention of further
disease concomitant with resolution of existing infection. Typical clinical procedures
involve thorough cleaning of the denture base material utilizing a 2.6% sodium
hypochlorite solution following removal of lining materials and preceding their
replacement (39). The cidal activity of this procedure is directly aimed at the fungal and
bacterial components of denture bases of DRS patients’ prostheses. While caustic to
fungal and bacterial pathogens, sodium hypochlorite is also very abusive to intraoral
tissues and may affect denture base chromaticity when not rinsed completely following
application. Fraud, et al. has stated in previous projects that low concentrations of AO
are safe for intraoral tissues, and even safe for intraoral use and application (10,11).
In this experimental procedure, the attempt to form a biofilm on PMMA in the
presence of varying amounts of AO yielded decreasing numbers of viable cells scraped
from the PMMA discs as AO concentration was increased. This result suggests that AO
is perhaps capable of either attacking and destroying fungal cells before they are able to
form the biofilm matrix, or more likely (given the presence of a biofilm on the PMMA
discs even at high AO concentrations) that AO is somehow thwarting the protective
characteristics of biofilms as they are formed by merely being incorporated into the
matrix as it develops. Further study into this mechanism of action is warranted.
Influence of AO on Salivary Pellicle Formation on PMMA Discs
DRS patients are instructed to follow a strict and time consuming protocol for
home care of their prosthesis in an effort to maintain the level of cleanliness between
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clinical visits. Even the most meticulous home care may not address and prevent the
recurrence of fungal, bacterial, and resultant biofilm reformation in hard to reach areas of
the prosthesis (39). Impossible to reach by any method of home care are the porous
portions of the denture (the base and overlying tissue conditioner lining material).
Because of the presence and physical characteristics of the lining material, home use of
sodium hypochlorite is not recommended, as incomplete removal of the hypochlorite
solution following application could exacerbate the soft tissue inflammation the clinician
and patient are striving to control.
In this experimental procedure, varying levels of AO were allowed to remain in
contact with PMMA discs in the presence of saliva for an 8 hour period of time prior to
introduction of fungal cells. As AO concentration increased, the number of viable cells
remaining in biofilm culture following a three hour incubation period decreased. These
results suggest that AO (when contact with PMMA is maintained for 8 hours) decreases
the number of viable C. albicans cells able to attach to PMMA. AO may function by
decreasing the number of cells capable of producing the biofilm, by weakening the matrix
itself as it is incorporated into the structure during development and maturation, or by
decreasing the adherence of saliva molecules to the PMMA which indirectly prevents
biofilm attachment. In any case, the results are interesting, and even the suggestion that
AO could modify the protective characteristic of biofilm environments warrants further
investigation into the matter.
Effect of AO Exposure Time on Viability of C. albicans
A concern of any treatment modality, regardless of the condition being addressed,
is patient compliance. The year 2009 has brought many advancements in technology that
have ‘streamlined’ human existence. Anecdotally, clinicians find that patient patience
and devotion to their prescribed care can sometimes fall short of expectation usually due
to the lack of devoted time. Treatment of DRS is often extremely frustrating for
clinicians as resolution of infection may take weeks to months of costly and frequent
clinical visits. While prescription of antifungal creams, troches, and systemic
medications have hastened the process of DRS treatment, it can remain painfully slow in
severe cases of the condition, particularly in non-compliant patients. The need for an
effective, easy, and efficient method to address DRS is greater than ever, particularly as
populations of the denture wearing community increase anually.
In this experimental procedure, a 0.001% AO concentration was exposed to
C. albicans cells derived from fresh culture and derived from biofilm culture for a
varying period of time. As exposure time increased, the number of viable cells remaining
in each culture source decreased, with biofilm-cultured C. albicans being more resistant
to AO than those from fresh culture, requiring 45 minutes for complete destruction of all
remaining cells. These results suggest that even at very low concentration of AO,
increasing the exposure time to the different cultures will eventually result in complete
destruction of any and all C. albicans cells derived from within and outside of a biofilm
environment. These results further suggest that AO possesses an effective and efficient
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mechanism of action, and that with a small increase in time, even low concentrations of
the surfactant maintains its fungicidal effect.
Effect of AO on Fresh and Biofilm-Cultured C. albicans
It is known that biofilm enviroments can evoke changes in the cells that inhabit
portions of its matrix—possibly by mechanical protection from host and antifungal
agents or even phenotypic alteration of the fungal cell itself (18,20). Regardless of the
mechanism, there is no doubt that a difference exists between cells before they become
encased in a biofilm and after they become encased in a biofilm. The question at this
point for researchers and clinicians alike is how can one circumvent the protective
features of that self-formed polymeric matrix, the biofilm.
In this experimental procedure, C. albicans cultured from both fresh and biofilm
environments were exposed to increasing concentrations of AO for 10 minutes, and were
then cultured for cell viability using the XTT method. As the concentration of AO was
increased, the number of viable cells in both groups decreased, with the biofilm-cultured
cells being more resistant to the fungicidal effect of AO. These results suggest that
although the protective properties of the once present biofilm persist in the biofilmcultured cells when exposed to AO, AO becomes effective against biofilm cells at higher
concentrations; the highest concentration tested in this case being 0.05% less than the
concentration safe for intraoral use (0.06%) identified by Fraud, et al. (10,11). This
series of experiments again suggest that AO possesses an effective and efficient
mechanism of action that, with an increase in concentration, can produce a fungicidal
effect to both fresh and biofilm-cultured fungal cells.
Effect of AO on Biofilm Formation on PMMA Discs
Perhaps the most clinically relevant procedure in this series of experiments
investigated the effect that AO has on biofilm cells embedded in the protective matrix
located on PMMA surfaces. This approach addressed the clinical manifestation and
challenges encountered in private practices and institutional dental settings worldwide.
To this point, AO has been introduced at either critical periods of biofilm development
(namely initiation) or following physical removal of cells from a biofilm environment.
The former attempting to discover AO’s effect on formation of the polymeric matrix and
subsequent resistance of fungal cells to AO’s established antifungal activity, and the
latter attempting to elucidate the change in response to AO between a freshly cultured
cell and a cell allowed to live and mature in a biofilm environment.
In this experimental procedure, PMMA discs were combined with fungal cells,
saliva, and supportive medium, and allowed to develop a biofilm matrix, undisturbed for
a 3 hour period of time. Following that period of incubation, varying concentrations of
AO were added to this medium for 10 minutes. Following that exposure time, the
PMMA discs were scraped, and fungal cells were isolated from the biofilm environment

25

in a method previously described, and were assayed for cell viability by the XTT method
also previously described.
These results suggest that AO is effective at killing cells as they are located within
a biofilm environment, particularly at higher concentrations of AO. Perhaps AO posseses
the ability to bypass the protective characteristics of the biofilm matrix.
Effect of AO on IL-1β Secretion by THP-1 Cells
The clinical manifestation of DRS is reliant upon inflammation mediated by
human monocyte release of inflammatory cytokines. The established effectiveness of
AO at decreasing the number of viable fresh and biofilm-cultured C. albicans while they
are located in and after they are separated from biofilm environments, means little if the
agents of the inflammatory process are not affected by AO’s activity.
In this experimental procedure, C. albicans cells cultured from fresh and biofilm
environments were exposed to varying concentrations of AO for 10 minutes, and then
exposed to human monocytes in a process and method previously described. The amount
of IL-1β (expressed in pg/mL) was assayed using the ELISA method previously
described. As the concentration of AO was increased, the amount of IL-1β released by
exposed THP-1 cells decreased. These results suggest that AO effectively reduces the
number of viable C. albicans cells to the point that it indirectly decreases THP-1 cell
activity in terms of IL-1β release.
Effect of AO on TNF-α Secretion by THP-1 Cells
In this experimental procedure, C. albicans cells cultured from fresh and biofilm
environments were exposed to varying concentrations of AO for 10 minutes, and then
exposed to human monocytes in a process and method previously described. The amount
of TNF-α (expressed in pg/mL) was assayed using the ELISA method previously
described. As the concentration of AO was increased, the amount of TNF-α released by
exposed THP-1 cells decreased. These results suggest that AO effectively reduces the
number of viable C. albicans cells to the point that it indirectly decreases THP-1 cell
activity in terms of TNF-α release.
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CHAPTER 7. CONCLUSION
Within the limitations of this study, results suggest that AO is effective at
reducing the number of viable C. albicans cells isolated from fresh and biofilm culture, as
well as fungal cells as they are located in a biofilm environment. Further, this series of
experiments also suggest that by reducing the number of viable fungal cells, AO is also
capable of indirectly decreasing the activity of human monocytes to release the
inflammatory cytokines IL-1β and TNF-α. Future investigations should address the
intraoral applications of AO, and its effectiveness in a clinical setting.
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